Is alectinib-induced elevation of creatine phosphokinase a predictive factor for response? Report of two cases and review of the literature.
Sign Up to like & getrecommendations! Published in 2021 at "Anti-Cancer Drugs"
DOI: 10.1097/cad.0000000000001043
Abstract: OBJECTIVE We aim to describe two cases of creatine phosphokinase (CPK) and liver enzymes elevation occurring as adverse effects of alectinib (Alecensa) treatment for anaplastic lymphoma kinase (ALK)-mutated metastatic nonsmall cell lung cancer (NSCLC). METHOD… read more here.
Keywords: elevation; creatine phosphokinase; response; cpk liver ... See more keywords